{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:44:14Z","timestamp":1766508254240,"version":"3.48.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"\n Background<\/jats:title>\n Percutaneous left atrial appendage (LAA) closure (LAAC) is a proven stroke prevention strategy for patients with atrial fibrillation (AF). However, incomplete sealing in complex LAA anatomies may compromise efficacy.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n This study evaluates the safety, feasibility, and efficacy of concomitant dual-device LAAC in multilobed anatomies, representing the largest cohort examined to date.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n We reviewed all LAAC procedures performed at the University Hospital of Bern between 2009 and 2025. Baseline characteristics, procedural details, and follow-up data were analyzed for patients receiving dual-device LAAC. Endpoints included technical success, complications, thromboembolic events, and device-related issues. Continuous data were expressed as mean\u2009\u00b1\u2009standard deviation or median values, while categorical data were reported as percentages. Group comparisons were conducted using\n t<\/jats:italic>\n -test, Mann\u2013Whitney\n U<\/jats:italic>\n test, or chi-square test. Differences were expressed as 95% confidence intervals, and a\n p<\/jats:italic>\n -value of less than 0.05 was considered significant.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 1,307 LAAC procedures, 10 included dual-device implantation. The mean age of the patients was 71\u2005years, and all patients were men. The Congestive heart failure, Hypertension, Age \u226575 years, Diabetes mellitus, prior Stroke or TIA, Vascular disease, Age 65\u201374 years, Sex category (CHA\n 2<\/jats:sub>\n DS\n 2<\/jats:sub>\n -VASc) and Hypertension, Abnormal renal\/liver function, Stroke, Bleeding history or predisposition, Labile INR, Elderly, Drugs\/alcohol (HAS-BLED) scores were 3.5\u2009\u00b1\u20091.8 and 2.9\u2009\u00b1\u20091.4, respectively. Most patients (70%) had paroxysmal AF. Preprocedural and intraprocedural transesophageal echocardiography (TEE) confirmed multilobed LAA anatomy in all cases. Half of the procedures were fluoroscopy-guided with one delivery sheath and transseptal puncture, while the other half were TEE-guided with a double sheath and two transseptal punctures. Only Amplatzer devices were used: Eight procedures employed two devices of the same type [five Amulet, three Amplatzer Cardiac Plug (ACP)], and two procedures combined different types (Amulet\u2009+\u2009ACP, ACP\u2009+\u2009Amplatzer Vascular Plug). Technical success was achieved in all cases. Within the first week, one (10%) patient experienced a clinically non-clinically relevant pericardial effusion. At 1-year follow-up (completed in nine patients), three (30%) patients developed pericarditis. No thromboembolic events, device-related thrombosis, or device embolization occurred.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n In this small cohort of patients with complex multilobed LAA anatomy, concomitant implantation of two Amplatzer devices proved to be a feasible strategy with acceptable short-term safety, although potentially associated with an increased risk of pericarditis.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1692521","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:25:48Z","timestamp":1766125548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Percutaneous left atrial appendage closure with concomitant dual-device implantation: a single-center observational study"],"prefix":"10.3389","volume":"12","author":[{"given":"Antanas","family":"Gasys","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Galea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Bini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Perich-Krsnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gamardella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Roten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George C. M.","family":"Siontis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.4244\/EIJ-D-19-00128","article-title":"Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study","volume":"15","author":"Cresti","year":"2019","journal-title":"EuroIntervention"},{"key":"B3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of peridevice leak on 5-year outcomes after left atrial appendage closure","volume":"80","author":"Dukkipati","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4244\/EIJY14M07_03","article-title":"Double device left atrial appendage closure","volume":"11","author":"Gu\u00e9rios","year":"2015","journal-title":"EuroIntervention"},{"key":"B6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijcard.2018.05.007","article-title":"Percutaneous left atrial appendage closure with complex anatomy by using the staged \u2018kissing-watchman\u2019 technology with double devices","volume":"265","author":"Jiang","year":"2018","journal-title":"Int J Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1039","DOI":"10.4244\/EIJ-D-19-00394","article-title":"Double device closure for large or bilobar left atrial appendage anatomy","volume":"16","author":"Alkhouli","year":"2020","journal-title":"EuroIntervention"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jcin.2019.02.047","article-title":"Double-Device closure of a large left atrial appendage","volume":"12","author":"Alkhouli","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"B9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.hjc.2020.03.005","article-title":"Dual device closure of a bilobar left atrial appendage with a plug (watchman 2.5\u2122 30 mm) and a pacifier (Amulet\u2122 20 mm) device","volume":"62","author":"Noutsias","year":"2021","journal-title":"Hellenic J Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"854475","DOI":"10.3389\/fcvm.2022.854475","article-title":"Occlusion of bilobulated left atrial appendage using the dual-watchman technique: a long-term follow-up study","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.jcin.2021.05.042","article-title":"Impact of echocardiographic guidance on safety and efficacy of left atrial appendage closure: an observational study","volume":"14","author":"Galea","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jcin.2024.01.310","article-title":"Pericardial effusion after left atrial appendage closure: timing, predictors, and clinical impact","volume":"17","author":"Galea","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"B13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.iccl.2024.07.002","article-title":"Antithrombotic therapy in patients undergoing percutaneous left atrial appendage occlusion","volume":"13","author":"Galea","year":"2024","journal-title":"Interv Cardiol Clin"},{"key":"B14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.31083\/j.rcm2412343","article-title":"Antithrombotic therapy after percutaneous left atrial appendage closure: evidence, challenges and future directions","volume":"24","author":"Galea","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.hrthm.2024.12.007","article-title":"Single versus dual antiplatelet therapy after left atrial appendage closure: a propensity score matching analysis","volume":"22","author":"Galea","year":"2025","journal-title":"Heart Rhythm"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jcin.2024.04.050","article-title":"Position statement on cardiac computed tomography following left atrial appendage occlusion","volume":"17","author":"Korsholm","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/europace\/euw141","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.hrthm.2006.07.022","article-title":"Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation","volume":"3","author":"Heist","year":"2006","journal-title":"Heart Rhythm"},{"key":"B20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or Watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial","volume":"145","author":"Galea","year":"2022","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1159\/000532019","article-title":"The effect of peri-device leaks on ischaemic stroke\/transient ischaemic attack\/systemic embolism after left atrial appendage closure: a systematic review and meta-analysis","volume":"148","author":"He","year":"2023","journal-title":"Cardiology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4244\/EIJ-D-19-00821","article-title":"Procedural and short-term outcomes of occluding large left atrial appendages with the LAmbre device","volume":"17","author":"Zhang","year":"2021","journal-title":"EuroIntervention"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jcin.2018.11.001","article-title":"Antithrombotic therapy and device-related thrombosis following endovascular left atrial appendage closure","volume":"12","author":"Saw","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/europace\/euad228","article-title":"Comparison of in-hospital outcomes and complications of left atrial appendage closure with the watchman device between males and females","volume":"25","author":"Alhuarrat","year":"2023","journal-title":"Europace"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14061787","article-title":"Epicardial ligation of the left atrial appendage in octogenarians: safety and long-term efficacy","volume":"14","author":"Nentwich","year":"2025","journal-title":"J Clin Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e34185","DOI":"10.1097\/MD.0000000000034185","article-title":"Amplatzer Amulet versus Watchman device for percutaneous left atrial appendage closure: a systematic review and meta-analysis","volume":"102","author":"Jaiswal","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.hrthm.2019.09.018","article-title":"Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: a US nationwide retrospective cohort study using claims data","volume":"17","author":"Vuddanda","year":"2020","journal-title":"Heart Rhythm"},{"key":"B29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jfma.2022.11.010","article-title":"Delayed pericardial effusion or tamponade following left atrial appendage closure: a single-center experience","volume":"122","author":"Fu","year":"2023","journal-title":"J Formos Med Assoc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijcard.2014.03.170","article-title":"Post-cardiac injury syndrome after permanent electronic cardiac device implantation. Incidence, presentation, management and long-term prognosis","volume":"174","author":"Gatzoulis","year":"2014","journal-title":"Int J Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1692521\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:18:47Z","timestamp":1766503127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1692521\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":30,"alternative-id":["10.3389\/fcvm.2025.1692521"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1692521","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"article-number":"1692521"}}